Page 828 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

784 INDEX INDEX

Necrosis (continued) jaundice in, 393 Neuroblastomas, 350 IL-8 and, 108
hernias and, 370 kernicterus, 194, 204 incidence and mortality, 222 innate immunity, 99
jaw, 486 Listeria monocytogenes in, 139 oncogenes and, 224 left shift, 424
mesenteric ischemia, 386 low birth weight, 635 paraneoplastic syndromes with, 228 in leukocyte adhesion deficiency,
nonalcoholic fatty liver disease, meningitis in, 182 Neurocutaneous disorders, 525 117
391 necrotizing enterocolitis and, 386 Neurodegenerative disorders, LTB4, 485
saponification, 209 obesity risk factors, 636 520–522 megaloblastic anemia, 420
scaphoid avascular, 449 pneumonia in, 149 drug therapy for, 549 in MI, 305
transplant reaction, 119 primitive reflexes in, 510 Neuroectoderm, 490 necrosis and, 209
warfarin, 436 sickle cell anemia in, 422 derivatives of, 612 nonmegaloblastic anemia, 420
Necrotizing enterocolitis, 386 Streptococcus agalactiae in, 137 pituitary gland, 327 pseudo-Pelger-Huet anomaly, 432
Necrotizing fasciitis, 479 TORCH manifestations in, 182 Neuroendocrine tumors, 350 stimulation of, 44
Streptococcus pyogenes (Group A Neoplasia Neurofibromatosis, 535 wound healing, 216
strep), 136 pathology of, 219–226, 518 chromosome association, 64 Nevi, 220
Necrotizing glomerulonephritis, 315 Neoplastic progression, 219 inheritance, 60 Nevirapine
Negative predictive value (NPV), 257 Neoplastic transformation, 216 tumor suppressor genes and, 224 cytochrome P-450 and, 252
Negative punishment, 554 adenomatous polyps, 387 typesI and II, 525 HIV therapy, 203
Negative reinforcement, 554 Neostigmine, 240 variable expressivity, 56 NF1/NF2 genes, 224
Negative skew distribution, 262 Nephritic-nephrotic syndrome Neurofilaments N-formylmethionine (fMet), 44
Negative-stranded viruses, 168 etiology and presentation, 595 cytoskeletal element, 48 NF-κB, 120
Neglect (child), 556 Nephritic syndrome, 596–597 immunohistochemical stain for, Niacin
Negri bodies, 171 etiology and presentation, 595 227 cutaneous flushing, 248
Neisseria gonorrhoeae Nephritis, 608 Neurogenic ileus, 240 gout, 250
culture requirements, 126 Nephroblastoma, 606 Neurohypophysis, 327 hyperglycemia, 249
epididymitis and orchitis, 654 Nephrocalcinosis, 211 hypothalamus and, 498 myopathy caused by, 250
osteomyelitis, 180 Nephrogenic diabetes insipidus, 211, Neuroleptic malignant syndrome Nicardipine, 318
septic arthritis, 468 338 (NMS), 551, 569 Nicotinamides, 75
STI, 184 lithium toxicity, 569 Neurological signs Nicotine
UTIs with, 600 treatment, 609 proximal upper and lower intoxication and withdrawal, 571
Neisseria meningitidis Nephrolithiasis, 606 extremity, 502 teratogenicity, 614
chloramphenicol, 192 calcium oxalate, 69 Neurologic drug reactions, 251 Nicotinic acetylcholine receptors,
culture requirements, 126 Nephron physiology, 585 Neurology and special senses, 166, 236
encapsulation, 127 Nephropathy 490–544 Niemann-Pick disease, 88
meningitis, 180 diabetes mellitus, 346 anatomy/physiology, 493–515 Nifedipine, 316, 318, 643
penicillin G/V for, 187 hypertension and, 300 embryology, 490–492 Nifurtimox, 158, 200
Waterhouse-Friderichsen protease inhibitors, 203 ophthalmology, 534–541 Night terrors
syndrome, 349 transplant rejection, 119 otology, 533–534 benzodiazepines for, 497
Neisseria spp Nephrotic syndrome, 597 pathology, 511–518 Nigrostriatal pathway, 499
C5-C9 deficiencies, 107 early-onset, 606 pharmacology, 544–551 Nikolsky sign
cephalosporins, 189 ESR in, 214 Neuromuscular blocking drugs, 551 blistering skin disorders, 480
fluoroquinolones, 195 etiology and presentation, 595 Neuromuscular disorders scalded skin syndrome, 479
gram-negative algorithm, 142 fatty casts in, 594 paraneoplastic syndromes, 228 Nilotinib, 443
IgA protease, 129 TBG and, 331 Neuromuscular junction Nimodipine, 318, 513
intracellular organism, 127 Nephrotoxicity skeletal muscle, 236 Nipple
transformation in, 130 aminoglycosides, 191 diseases of, 472 intraductal papilloma, 649
Nelson syndrome, 348 amphotericin B, 199 Neurons, 493 lactational mastitis, 649
Nematodes, 159 cidofovir, 202 in ascending spinal tracts, 509 Nissl bodies, 46
infection routes, 158 cisplatin/carboplatin, 442 local anesthetics, 550 Nissl substance
Neomycin cladribine, 440 origins of, 490 chromatolysis, 495
aminoglycosides, 191 drug reaction and, 251 Parkinson disease, 548 neurons, 493
Neonatal abstinence syndrome, 615 drugs causing, 444 primary motor cortex, 509 Nitazoxanide, 155
Neonatal conjunctivitis immunosuppressants, 120 Neuron-specific enolase, 226, 350 Nitrates, 319
Chlamydia trachomatis, 149 inhaled anesthetics, 550 Neuropathic pain, 515 mechanism and clinical use, 318
Neonatal pneumonia streptomycin, 197 Neuropathy Nitric oxide, 371
Group B streptococci, 179 sulfonamides, 194 diabetes mellitus, 346 free radical injury and, 210
Neonatal respiratory distress Nerve blockade (local anesthetics), Neurosyphilis, 147 Nitrites
syndrome (NRDS), 661 550 Neurotoxicity urinary tract infections, 181
Neonates Nerve fibers, 495 cladribine, 440 Nitroblue tetrazolium dye reduction
abstinence syndrome, 615 Nerves immunosuppressants, 120 test, 117
Apgar score, 634 lower extremity, 452, 453 methylmercury exposure, 614 Nitrofurantoin
Candida albicans in, 153 upper extremity, 446, 447 methylxanthines, 687 hemolysis in G6PD deficiency, 250
coagulation cascade in, 413 Nerve trunk, 495 vincristine, 441 pulmonary fibrosis, 251
conjunctivitis, 142, 149 Nesiritide, 296 Neurotransmitters Nitroglycerin, 318
deprivation effects, 556 Neural crest bacterial toxin effects, 132 acute coronary syndromes, 307
esophageal atresia in, 359 derivatives of, 613 changes with disease, 495 angina, 304
flora with C-section, 178 Neural crest cells, 490, 494 vomiting center receptors, 496 Nitroprusside, 318
galactosemia in, 80 Neural development, 490 Neurovascular pairing, 455 Nitrosamines
gastroenteritis, 168 Neural plate, 490 Neutralization (antibody), 104 as carcinogens, 225
gray baby syndrome in, 192 Neural tube, 490 Neutropenia, 424 stomach cancer and, 379
hemolytic anemia in, 422 derivatives, 613 ganciclovir, 202 Nitrosoureas, 441
herpes in, 164 formation, 612 rheumatoid arthritis, 466 Nitrous oxide, 550
hyperthermia in, 241 Neural tube defects, 491 ticlopidine, 437 Nizatidine, 399
hypertrophic pyloric stenosis in, maternal diabetes, 614 Neutrophils, 406 NMDA receptor antagonist
359 prevention, 68 chemotaxis, 44, 106, 133, 406, 485, ketamine as, 550
indirect inguinal hernia in, 370 valproic acid, 544 487, 691 memantine as, 549
intraventricular hemorrhage, 512 Neuraminidase, 169–170 corticosteroid effect on, 424 N-myc oncogene, 350

FAS1_2019_21_Index_749-806.indd 784 11/21/19 12:27 PM